These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 17447172)

  • 1. Clinical and social determinants of antipsychotic polypharmacy for Chinese patients with schizophrenia.
    Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
    Pharmacopsychiatry; 2007 Mar; 40(2):47-52. PubMed ID: 17447172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the clinical and social determinants of prescribing anticholinergic medication for Chinese patients with schizophrenia.
    Xiang YT; Weng YZ; Leung CM; Tang WK; Sandor UG
    Hum Psychopharmacol; 2007 Apr; 22(3):173-80. PubMed ID: 17397098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and social determinants of long-term use of benzodiazepines and its impact on quality of life of Chinese schizophrenia patients.
    Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
    Pharmacopsychiatry; 2007 Nov; 40(6):269-74. PubMed ID: 18030651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and social determinants of psychotropic drug prescription for schizophrenia outpatients in China.
    Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS; Gerevich J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):756-60. PubMed ID: 17289236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and social correlates with the use of depot antipsychotic drugs in outpatients with schizophrenia in China.
    Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
    Int J Clin Pharmacol Ther; 2008 May; 46(5):245-51. PubMed ID: 18538110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic polypharmacy in inpatients with schizophrenia in Asia (2001-2009).
    Xiang YT; Wang CY; Si TM; Lee EH; He YL; Ungvari GS; Chiu HF; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong KH; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N
    Pharmacopsychiatry; 2012 Jan; 45(1):7-12. PubMed ID: 21989602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical correlates of clozapine prescription for schizophrenia in China.
    Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS
    Hum Psychopharmacol; 2007 Jan; 22(1):17-25. PubMed ID: 17191268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing for inpatients with schizophrenia: an international multi-center comparative study.
    Bitter I; Chou JC; Ungvari GS; Tang WK; Xiang Z; Iwanami A; Gaszner P
    Pharmacopsychiatry; 2003 Jul; 36(4):143-9. PubMed ID: 12905100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.
    Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L
    Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
    Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A
    Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic polypharmacy and risk of death from natural causes in patients with schizophrenia: a population-based nested case-control study.
    Baandrup L; Gasse C; Jensen VD; Glenthoj BY; Nordentoft M; Lublin H; Fink-Jensen A; Lindhardt A; Mortensen PB
    J Clin Psychiatry; 2010 Feb; 71(2):103-8. PubMed ID: 19895781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison.
    Roh D; Chang JG; Kim CH; Cho HS; An SK; Jung YC
    Aust N Z J Psychiatry; 2014 Jan; 48(1):52-60. PubMed ID: 23671214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of anticholinergic drugs in patients with schizophrenia in Asia from 2001 to 2009.
    Xiang YT; Wang CY; Si TM; Lee EH; He YL; Ungvari GS; Chiu HF; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong KH; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N
    Pharmacopsychiatry; 2011 May; 44(3):114-8. PubMed ID: 21491361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The trend for megadose polypharmacy in antipsychotic pharmacotherapy: a prescription survey conducted by the psychiatric clinical pharmacy research group].
    Yoshio T
    Seishin Shinkeigaku Zasshi; 2012; 114(6):690-5. PubMed ID: 22844820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic polypharmacy at the University Psychiatric Hospital in Serbia.
    Divac N; Jasović-Gasić M; Samardzić R; Lacković M; Prostran M
    Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1250-1. PubMed ID: 17960865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009.
    Yoshio T; Inada T; Uno J; Miwa T; Kitagawa K; Miyahara Y; Umeda K; Kato T; Inagaki A; Nabeshima T
    Hum Psychopharmacol; 2012 Jan; 27(1):70-5. PubMed ID: 22249957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient characteristics and process factors associated with antipsychotic polypharmacy in a nationwide sample of psychiatric inpatients in Italy.
    Santone G; Bellantuono C; Rucci P; Picardi A; Preti A; de Girolamo G
    Pharmacoepidemiol Drug Saf; 2011 May; 20(5):441-9. PubMed ID: 21523847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China.
    Li Q; Xiang YT; Su YA; Shu L; Yu X; Chiu HF; Correll CU; Ungvari GS; Lai KY; Ma C; Wang GH; Bai PS; Li T; Sun LZ; Shi JG; Chen XS; Mei QY; Li KQ; Si TM
    Aust N Z J Psychiatry; 2015 Feb; 49(2):129-36. PubMed ID: 24923760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.